Navigation Links
Founder of Enron, Ken Lay Passes Away

Colorado: Ken Lay, the founder of Enron, who was admitted at the Aspen Valley Hospital with a massive coronary, passed away, in the early morning due to a heart attack//.

The founder and the supposed mastermind behind the Enron scandal had succumbed to his illness just months before his impending sentence on his involvement in the scandal. In May the founder of the Enron Corp. was convicted on 10 counts of fraud and conspiracy on the investors and employees by repeatedly lying about Enron's finances.

It was reported that one point in time, the company was ranked the seventh largest in the nation before the scandal and corruption had caused the company to collapse. Ken Lay and former Enron CEO, Jeffrey Skilling, were to have faced the judge for their sentence on 23rd Oct 2006. Legal experts were of the opinion that both men would face up to 40 years in prison for their actions. Ken Lay was supposedly a patient with a history of heart attack, as he had received previous treatment for his heart ailment. But many experts are of the opinion that he stress of the scandal and the ongoing trail could have been the major contributing cause for his massive coronary this time around.

Ken Lay is survived by a large family and friends. Kelly Kimberly, the family spokeswoman, in a statement said, “the Lays have a very large family with whom they need to communicate, and out of respect for the family we will release further details at a later time.”

'"/>




Page: 1

Related medicine news :

1. President and Founder of National Obesity Forum Resigns
2. Eye Hospital Founder a Beacon Light for Ophthalmologists: Kalam
3. Body Shop Founder’s New Project-against Hepatitis
4. Organ Donation Crusader Passes Away
5. A Mother Passes On A Rare, Terminal Brain Disease To Her Three Children
6. Renowned Doctor Passes Away
7. Maoist Leader-Turned Social Activist Passes Away
8. Jeff Getty, AIDS Activist, Passes Away
9. WHO Passes Rotavirus Vaccine
10. US Senate Passes Stem Cell Research Bill
11. Texas Passes Bill To Halt Order Mandating HPV Vaccine for School Girls
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Founder Enron Ken Lay Passes Away

(Date:5/16/2008)...sents Urban Health Institute with 10,000 Sensual O...rg at Playboy Mansion Fundraiser, LOS ANGELES, Ma...ip-hop,and R & B artist J Kwon known best for his ...ll be presenting the Urban Health Institute (UHI) ... over $50,000. The donation is,being made to promo...
(Date:5/16/2008)...docs determine who would benefit most from chemo a... 16 (HealthDay News) -- A panel of 15 genes may he...mall cell lung cancer will experience a recurrence...y, a new study shows. , By extension, the same... less aggressive forms of the cancer who would be ...
(Date:5/16/2008)...TON, May 16 /PRNewswire-USNewswire/ -- As tropical...e Irrawaddy delta, survivors of,Cyclone Nargis are... Many,survivors still need assistance, as exposure... an increasingly dire situation., "The people liv...,recover from this disaster and get back on their ...
(Date:5/16/2008)...h Funding Per Death Drops More in 2007, WASHINGTO...ncer causes,one in three cancer deaths, the Nation... its $4.8 billion budget in lung cancer research i...Lung Cancer Alliance (LCA) today., The two other ...programs -- Centers for Disease Control and Preven...
Breaking Medicine News(10 mins):Health News:Everybody in the Club Scream O! 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Myanmar Cyclone Survivors Face New Challenges 2Health News:Lung Cancer Still Lowest in Federal Funding 2
...o a better job of keeping metabolism on track when...ht be helping people keep the pounds off for good,...such as white bread, refined breakfast cereals, an...ing a quick rise in blood sugar and insulin. This ...
...ecent study researchers now say that the antidepre...a higher risk // of being admitted to a hospital ...rom 1992 to 2000 on over 64,000 new antidepressant...otonin reuptake inhibition levels on the risk for ...
...hours does not only cause fatigue but can also be ... on an airplane for several// hours can cause deep...in which blood clots form in the leg or pelvic vei...with health conditions that promote clotting, such...
...f the knee is very common, affecting almost one-te...is an incurable illness //, so treatment is aimed ...hy acupuncture was studied. Acupuncture in additio... is more effective than drug treatment alone, show...
Other Medicine News:
(Date:5/15/2008)...ELL, Switzerland, May 15 /- Ergonex P...and Drug Administration (FDA) has,granted orphan d...pulmonary,arterial hypertension (PAH). Terguride i...hase II trial in Europe., "The FDA,s grant of orp...es and strengthens our development program by offe...
(Date:5/15/2008)... SPRINGS, Fla., May 15 /- Tigris Phar... a Cooperative Research and,Development Agreement ...o,collaborate on clinical and preclinical developm... I development. AFP-464 is converted to,metabolite...ctivation and,apoptosis., This is part of a four-...
(Date:5/15/2008)...le Opportunity Remains for an Antiplatelet Therapy...g than the Combination of Plavix/Iscover and A...sources, WALTHAM, Mass., May 15 /- D...arch and advisory firms for pharmaceutical and,hea...y,s Effient offers,improvement in patient compared...
(Date:5/15/2008)... Data Expected soon after CEA Trial data reports i...-, SAN FRANCISCO, May 15 /...otechnology company focused on the development of,...ase, announced today that,it has completed patient...tudy. The ACS study is one of three Phase 2 trials...
Breaking Medicine Technology:Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6 2007 285 1New technique detects specific chromosomal damage may indicate lung cancer risk 292 1New technique detects specific chromosomal damage may indicate lung cancer risk 292 2ResMed Names Kieran Gallahue as Chief Executive Officer Effective January 1 2008 290 1ResMed Names Kieran Gallahue as Chief Executive Officer Effective January 1 2008 290 2UHW Announces 3A Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW West 287 1UHW Announces 3A Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW West 287 2
...ASHINGTON, June 01, 2007 /PRNewswire/ -- The annua...Centers (CMSC), the largest,meeting devoted to the...sis (MS), is underway in the nation,s capital toda...rvous system that affects,400,000 people in the Un...d healthcare professionals in many ways. The meeti...
...hicago, IL -- CytImmune, a clinical stage nanomedi...cialization of,multifunctional, tumor-targeted the...rd American Society of Clinical Oncology (ASCO),An...sults of a,Phase 1 Clinical Trial of CYT-6901," an...Institute conducted and CytImmune Sciences,sponsor...
Other Medicine Technology:Annual Meeting of the Consortium of Multiple Sclerosis Centers,Focuses on the Challenges of Care and Research in Multiple,Sclerosis 2Annual Meeting of the Consortium of Multiple Sclerosis Centers,Focuses on the Challenges of Care and Research in Multiple,Sclerosis 3CytImmune Presents Positive CYT-6019 Data During the American,Society of Clinical Oncology Annual Meeting in Chicago 2CytImmune Presents Positive CYT-6019 Data During the American,Society of Clinical Oncology Annual Meeting in Chicago 3
The dual-electrode SPL defibrillator lead features a patented coiled-coil electrode design, offering the flexibility and maneuverability of a pacemaker lead. Designed for the physician who prefers a
TVL defibrillation leads have a patented coiled-coil design for faster, easier insertion and more precise intracardiac placement. Designed with an integrated bipolar design, the lead enables high-vol
The Livewire steerable electrophysiology catheter is uniquely designed with an ergonomic handle and patented steering mechanism to provide smooth, precise catheter tip movement, even during lengthy e
...ar-spaced electrodes along a circular tip, providi...ial fibrillation procedures. High resolution mappi...npointing of pulmonary vein potentials than with 1...iency in the catheter-based management of atrial f...
Medicine Products: